Profound Medical Present at the Canaccord Genuity 40th Annual Growth Conference

TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced today that management will present an update on the Company’s business at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020, at 9:30 a.m. Eastern Time via webcast.